PDF
File
Kurs & Likviditet
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Between May 26-28th 2022, our product specialist Elin Wallin and our CEO Mohan Frick will participate in ESVONC's annual congress in Italy. A poster on treatment with our TSE™ technology has been accepted and will also be presented there.
The poster that has been accepted is written by Majbritt Larsen, Veterinarian with specialist competence in dog and cat diseases, responsible for Oncology Evidensia Specialist Animal Hospital Helsingborg and presents the outcome from the treatment of sarcoids in a horse, which we published on 16 Nov 2021. Majbritt will herself attend and present her poster at the congress.
"We already had high expectations for this congress, which we believe will give many rings on the water for the continued launch of TSEs in veterinary medicine. The fact that we now also have a poster on TSE that will be presented by Majbritt, in front of many other of Europe's leading veterinarians, gives us the attention that definitely strengthens the chances of continued success. " - says Mohan Frick, CEO and co-founder ChemoTech
ESVONC
The European Society of Veterinary Oncology (ESVONC) was established on September 24[th] in 1992 by a group of scientists, active in the field of veterinary and comparative oncology in Europe.
- A poster is a scientific summary of a project/study carried out with a positive and interesting outcome that is presented to arouse interest.